On Monday, manufacturer Actavis announced a nationwide recall of its painkiller patches containing fentanyl due to a product defect that could result in drug overdose among patients and caregivers. The recall includes patches with an Abrika or Actavis label delivering 25, 50, 75 and 100 micrograms per hour with expiration dates of May through August 2009. This recall comes a week after a Johnson & Johnson unit pulled its fentanyl patches (Duragesic patches). The defect which can cause the patch to leak and expose patients or caregivers directly to the fentanyl gel. Exposure to fentanyl gel may lead to serious adverse events, including respiratory distress and possible overdose, which may be fatal.
Comments are closed.